Galena Biopharma Hires Hana B. Moran as Vice President, Regulatory Affairs and Compliance
October 04, 2011 07:05 ET
|
Galena Biopharma, Inc.
LAKE OSWEGO, Ore., Oct. 4, 2011 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (Nasdaq:RXII), a biotechnology company focused on developing innovative, targeted oncology treatments that address major...
RXi Pharmaceuticals(R) to Strengthen Strategic Focus by Separating Into Two Publicly Traded Companies
September 26, 2011 06:55 ET
|
Galena Biopharma, Inc.
Galena Biopharma(TM) to Focus on Targeted Cancer Therapies
RXi Pharmaceuticals to Focus on RNAi-Based Therapeutics
Separation of oncology and RNAi programs expected to enhance shareholder...
RXi Pharmaceuticals Licenses Novel, Targeted Cancer Vaccine for Gynecological Cancers
September 21, 2011 07:09 ET
|
Galena Biopharma, Inc.
Vaccine targets Folate Binding Protein (FBP) which is over-expressed in more than 90% of ovarian cancers and in the majority of other adenocarcinomas.
RXi plans to initiate Phase 1 clinical...
RXi Pharmaceuticals Provides Positive NeuVax(TM) Phase 3 Clinical Trial Update
September 12, 2011 07:05 ET
|
Galena Biopharma, Inc.
The CMC partial clinical hold has been lifted by the FDA, allowing the pivotal Phase 3 trial to commence.
RXi has assigned a principal investigator and initial IRB approvals received--going...
RXi Pharmaceuticals to Present at the 13th Annual Rodman & Renshaw Healthcare Conference
September 08, 2011 07:10 ET
|
Galena Biopharma, Inc.
WORCESTER, Mass., Sept. 8, 2011 (GLOBE NEWSWIRE) -- RXi Pharmaceuticals Corporation (Nasdaq:RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies...
RXi Pharmaceuticals Presents RNAi Data at the 7th Annual Meeting of the Oligonucleotide Therapeutics Society
September 07, 2011 07:05 ET
|
Galena Biopharma, Inc.
WORCESTER, Mass., Sept. 7, 2011 (GLOBE NEWSWIRE) -- RXi Pharmaceuticals Corporation (Nasdaq:RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies...
RXi Pharmaceuticals Provides Update and Reports Financial Results for Q2 2011
August 15, 2011 20:08 ET
|
Galena Biopharma, Inc.
NeuVax™ (E75) makes significant progress towards initiating the Phase 3 PRESENT (Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2...
RXi Pharmaceuticals to Present at the Wedbush Securities 2011 Life Sciences Management Access Conference
August 12, 2011 07:05 ET
|
Galena Biopharma, Inc.
WORCESTER, Mass., Aug. 12, 2011 (GLOBE NEWSWIRE) -- RXi Pharmaceuticals Corporation (Nasdaq:RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies...